
McKesson
MCK · NYSE · Health Care
Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time
- Market cap
- $128 bn
- Div. yield
- 0,5%
- Year to date
- +34,4%
Ratio score
based on 9 metrics as of 16.11.2026 ·
Verdict by our methodology based on current metrics. Not an investment recommendation.
Key metrics
5 ✓ · 3 — · 1 ✕ · 1 n/a · hover over a row or tap it to see the trend
All metrics
| Metric | Value | 5-year median | Industry median |
|---|---|---|---|
| P/E TTM | 27,3 | 23,5 | 25,1 |
| Forward P/E | 20,7 | — | 16,2 |
| PEG | 2,2 | — | 2,2 |
| P/S | 0,3 | 0,2 | 2,2 |
| EV/EBITDA | 18,8 | 17,0 | 17,3 |
| P/FCF | 17,7 | — | 19,5 |
| P/B | 21,8 | 3,5 | 3,4 |
Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.
Price chart
Compare with
Choose a stock
Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.
Analysts
Ratings, 22 analysts
- Buy
- 18
- Hold
- 4
- Sell
- 0
Beat the EPS forecast in 4 of the last 4 quarters
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Q2 2027 | 10,81 | 11,68 | Up +8,0% |
| Q1 2027 | 9,63 | 9,93 | Up +3,1% |
| Q4 2026 | 11,68 | 11,69 | Up +0,1% |
| Q3 2026 | 9,31 | 9,34 | Up +0,3% |
Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.
Financials in charts
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 111 bn | 105 bn | 96,3 bn | 106 bn | 103 bn | 97,8 bn | 90,8 bn | 95,3 bn | 93,7 bn | 79,3 bn | 76,4 bn | 80,9 bn |
| EPS | 10,44 | 5,15 | 13,65 | 9,59 | 8,92 | 6,25 | 9,92 | 6,95 | 1,87 | 7,00 | 6,00 | 4,42 |
| Margin | 1,1% | 0,6% | 1,7% | 1,1% | 1,1% | 0,8% | 1,4% | 0,9% | 0,3% | 1,2% | 1,0% | 0,7% |
| FCF | 3,01 bn | −332 m | 3,31 bn | 1,12 bn | 2,31 bn | −1,03 bn | 7,58 bn | −2,51 bn | 1,96 bn | −1,49 bn | 3,96 bn | 164 m |
From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.
Owners
Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.
Insider trades over 12 months
Over 12 months: no purchases, sales $29,3 m.
| Name | Amount | Shares | Price |
|---|---|---|---|
| fraga francisco5 Nov 2026 · sale | $716 924 | 650 | $1 102,96 |
| fraga francisco4 Nov 2026 · sale | $630 000 | 600 | $1 050,00 |
| rutledge napoleon b jr8 Sep 2026 · sale | $98 951 | 111 | $891,45 |
| lerman bradley e10 Aug 2026 · sale | $268 590 | 301 | $892,33 |
| tyler brian s.7 Jul 2026 · sale | $6,72 m | 8 463 | $793,56 |
| tyler brian s.17 Jun 2026 · sale | $6,56 m | 8 463 | $775,13 |
| tyler brian s.9 Jun 2026 · sale | $3,76 m | 4 929 | $763,00 |
| rutledge napoleon b jr5 Jun 2026 · sale | $101 612 | 133 | $764,00 |
| rodgers thomas l2 Jun 2026 · sale | $513 954 | 699 | $735,27 |
| rodgers thomas l1 Jun 2026 · sale | $90 467 | 123 | $735,50 |
| smith leann b1 Jun 2026 · sale | $1,33 m | 1 810 | $735,50 |
| lau michele26 May 2026 · sale | $2,70 m | 3 550 | $761,09 |
| rodgers thomas l26 May 2026 · sale | $1,82 m | 2 388 | $761,09 |
| lau michele2 Mar 2026 · sale | $2,70 m | 2 725 | $990,00 |
| martinez maria19 Feb 2026 · sale | $328 013 | 349 | $939,87 |
SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.
About the company
- Industry
- Health Care
- Exchange
- NYSE
- Country
- US
- IPO date
- 10 Nov 1994
- Website
- www.mckesson.com
Company description, revenue by segment and region, and the CEO will come later.
Earnings
- Next report
- date not announced
An AI summary of the earnings call will come later.
Peers
| Company | Price | ||||
|---|---|---|---|---|---|
MDTMedtronic | $102,88 | 78★★★★★★★★★would consider | 25,1 | +9,8% | 13,9% |
SYKStryker Corporation | $310,72 | 72★★★★★★★★★would consider | 33,0 | +7,9% | 13,8% |
CVSCVS Health | $88,59 | 83★★★★★★★★★would consider | 10,4 | +6,7% | 2,6% |
ISRGIntuitive Surgical | $437,75 | 83★★★★★★★★★would consider | 52,0 | +20,5% | 25,5% |
HCAHCA Healthcare | $511,78 | 69★★★★★★★★★would watch | 15,4 | +5,8% | 8,6% |
Ratio — a score by our methodology, not an investment recommendation.




